Peripheral biomarker analysis in patients with advanced urothelial carcinoma (UC) after platinum chemotherapy treated with cabozantinib (CABO) plus durvalumab (DURVA): Preliminary analysis from the phase 2 ARCADIA trial.

Autor: Giannatempo, Patrizia, Sgambelluri, Francesco, Stellato, Marco, Guadalupi, Valentina, Raggi, Daniele, Rametta, Alessandro, Bottiglieri, Achille, Claps, Melanie, Walter, Ferrari Bravo, Oldani, Simone, Zimatore, Matteo, Calareso, Giuseppina, Alessi, Alessandra, Cattaneo, Laura, Verzoni, Elena, De Braud, Filippo G., Procopio, Giuseppe, Necchi, Andrea, Anichini, Andrea, Mortarini, Roberta
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p684-684, 193p
Databáze: Supplemental Index